MarketIQ Analyst Report for Roper Technologies, Inc. Common Stock

6901 PROFESSIONAL PKWY EAST, SUITE 200, SARASOTA, FL, US
ROP

Last Updated: 07 Nov 2024

Executive Summary

Roper Technologies (ROP) is a diversified industrial company with a market capitalization of $58.19 billion. The company operates in the life sciences, industrial technologies, and software and services sectors. ROP has a strong financial position with an EBITDA of $2.73 billion and a profit margin of 21.8%. The company is expected to continue to grow in the future, with analysts predicting a 12-month price target of $612.51.

Company Overview

Roper Technologies was founded in 1981 and is headquartered in Sarasota, Florida. The company has over 25,000 employees and operates in over 50 countries. ROP's products are used in a variety of industries, including healthcare, transportation, and manufacturing.

Fundamental Analysis

ROP has a strong financial position with an EBITDA of $2.73 billion and a profit margin of 21.8%. The company's revenue has grown by an average of 12.9% over the past five years. ROP is also expected to continue to grow in the future, with analysts predicting a 12-month price target of $612.51.

Technical Analysis

ROP's stock price has been trending higher in recent months. The stock is currently trading above its 50-day and 200-day moving averages. The stock's relative strength index (RSI) is also above 50, which indicates that the stock is overbought.

Short Term Outlook

ROP's stock price is expected to continue to trend higher in the short term. The stock is currently trading above its 50-day and 200-day moving averages, and the RSI is above 50. This indicates that the stock is in a bullish trend.

Long Term Outlook

ROP's long-term outlook is also positive. The company is expected to continue to grow in the future, with analysts predicting a 12-month price target of $612.51. ROP's strong financial position and its presence in growing markets make it a good long-term investment.

Analyst Recommendations

Analysts are bullish on ROP's stock. The consensus recommendation is a "buy" with a 12-month price target of $612.51.